| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | President &COO +2 more
3 companies
Greenstreet Yvonne is a Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 36 sells.
Estimated insider holdings value: $23.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 15,148 | $270.00 | $4,089,960.00 | -17.1% | +4.8% | +49.6% | |
| Jul 11, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 7,093 | $261.00 | $1,851,273.00 | -8.8% | +3.8% | +20.7% | |
| Jun 25, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,301 | $230.99 | $1,917,475.08 | -0.8% | +13.2% | +34.1% | |
| Feb 28, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 2,932 | $155.31 | $455,357.07 | -1.2% | -3.3% | +52.7% | |
| Feb 16, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 7,030 | $148.06 | $1,040,884.56 | -4.8% | +2.9% | +74.5% | |
| Aug 4, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 4,057 | $185.85 | $753,986.38 | -1.8% | -13.0% | +46.6% | |
| Apr 27, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 7,615 | $194.59 | $1,481,811.47 | -4.4% | -0.6% | -26.9% | |
| Aug 6, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | President &COO | Sale+OE | 53,064 | $199.00 | $10,559,736.00 | -82.8% | -5.0% | +12.0% | |
| Jan 12, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | President &COO | Sale+OE | 3,125 | $161.00 | $503,125.00 | -39.3% | - | - | |
| Jul 10, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 46,639 | $161.00 | $7,508,879.00 | -90.6% | - | - |